585 related articles for article (PubMed ID: 25229548)
1. DNA methylation biomarkers: cancer and beyond.
Mikeska T; Craig JM
Genes (Basel); 2014 Sep; 5(3):821-64. PubMed ID: 25229548
[TBL] [Abstract][Full Text] [Related]
2. DNA Methylation Cancer Biomarkers: Translation to the Clinic.
Locke WJ; Guanzon D; Ma C; Liew YJ; Duesing KR; Fung KYC; Ross JP
Front Genet; 2019; 10():1150. PubMed ID: 31803237
[TBL] [Abstract][Full Text] [Related]
3. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
4. Young women with poor ovarian response exhibit epigenetic age acceleration based on evaluation of white blood cells using a DNA methylation-derived age prediction model.
Hanson BM; Tao X; Zhan Y; Jenkins TG; Morin SJ; Scott RT; Seli EU
Hum Reprod; 2020 Nov; 35(11):2579-2588. PubMed ID: 33049778
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
Singh A; Gupta S; Sachan M
Front Cell Dev Biol; 2019; 7():182. PubMed ID: 31608277
[TBL] [Abstract][Full Text] [Related]
6. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
Jankowska AM; Millward CL; Caldwell CW
Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
8. Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.
Willmer T; Johnson R; Louw J; Pheiffer C
Front Endocrinol (Lausanne); 2018; 9():744. PubMed ID: 30564199
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
Wong CC; Li W; Chan B; Yu J
Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
Toiyama Y; Okugawa Y; Goel A
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
[TBL] [Abstract][Full Text] [Related]
11. Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?
Hentze JL; Høgdall CK; Høgdall EV
Mol Clin Oncol; 2019 Mar; 10(3):323-330. PubMed ID: 30847169
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation signatures as biomarkers of prior environmental exposures.
Ladd-Acosta C; Fallin MD
Curr Epidemiol Rep; 2019 Mar; 6(1):1-13. PubMed ID: 31032172
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation profiles in cancer diagnosis and therapeutics.
Pan Y; Liu G; Zhou F; Su B; Li Y
Clin Exp Med; 2018 Feb; 18(1):1-14. PubMed ID: 28752221
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic diagnostics of cancer--the application of DNA methylation markers.
Paluszczak J; Baer-Dubowska W
J Appl Genet; 2006; 47(4):365-75. PubMed ID: 17132902
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation as clinically useful biomarkers-light at the end of the tunnel.
Levenson VV; Melnikov AA
Pharmaceuticals (Basel); 2012 Jan; 5(1):94-113. PubMed ID: 24288045
[TBL] [Abstract][Full Text] [Related]
16. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.
Fukushige S; Horii A
Tohoku J Exp Med; 2013 Mar; 229(3):173-85. PubMed ID: 23419314
[TBL] [Abstract][Full Text] [Related]
18. DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies.
Larsen LK; Lind GE; Guldberg P; Dahl C
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151158
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation based biomarkers in colorectal cancer: A systematic review.
Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]